Khattar Jack A.
- SEC CIK
- 0001539937
In the past year, 6 open-market sale filings worth $7.72M and no purchases.
Current role at each company
- SUPN Supernus Pharmaceuticals, Inc.President, CEOas of Aug 14, 2026
- CGTX Cognition Therapeutics IncDirectoras of Jun 22, 2026
- SCPH scPharmaceuticals Inc.Directoras of Oct 7, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $7.72M
- 6 filings
- Net
- −$7.72M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Khattar Jack A. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SUPN Supernus Pharmaceuticals, Inc.
President, CEO32 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Khattar Jack A.President, CEO | SSale | −117.9K | $31.46 | −$3.71M | −14.4%701.3K after | 2 lots |
| Aug 10, 2022 (view filing) | Aug 9 | 1 day | Khattar Jack A.President, CEO | SSale | −39.4K | $31.15 | −$1.23M | −5.2%725.0K after | |
| Aug 11, 2022 (view filing) | Aug 10 | 1 day | Khattar Jack A.President, CEO | SSale | −28.4K | $31.22 | −$887.8K | −3.7%741.4K after | |
| Aug 17, 2022 (view filing) | Aug 15 | 2 days | Khattar Jack A.President, CEO | SSale | −17.3K | $34.03 | −$588.8K | −2.2%759.9K after | |
| Aug 18, 2022 (view filing) | Aug 16 | 2 days | Khattar Jack A.President, CEO | SSale | −14.7K | $34.01 | −$499.6K | −1.9%775.6K after | |
| Nov 17, 2022 (view filing) | Nov 15 | 2 days | Khattar Jack A.President, CEO | SSale | −1.11K | $35.00 | −$39.0K | −0.1%780.7K after | |
| Nov 22, 2022 (view filing) | Nov 21 | 1 day | Khattar Jack A.President, CEO | SSale | −531 | $35.01 | −$18.6K | −0.1%781.1K after | |
| Nov 23, 2022 (view filing) | Nov 22 | 1 day | Khattar Jack A.President, CEO | SSale | −600 | $35.00 | −$21.0K | −0.1%781.4K after | |
| Nov 28, 2022 (view filing) | Nov 23-25 | 5 days | Khattar Jack A.President, CEO | SSale | −13.4K | $35.16 | −$470.9K | −1.7%789.4K after | 2 lots |
| Dec 22, 2022 (view filing) | Dec 20-21 | 2 days | Khattar Jack A.President, CEO | SSale | −15.4K | $38.11 | −$585.3K | −1.9%814.7K after | 2 lots |
SCPH scPharmaceuticals Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2021 (view filing) | Dec 3 | 3 days | Khattar Jack A.Director | PPurchase | +5.00K | $3.91 | +$19.6K | New position5.00K after |